APA (7th ed.) Citation

M, Y., Y, W., J, G., C, Z., Y, C., A, G., . . . Y, Y. (2026). Decreased PP2A expression and activity represent a therapeutic target for plexiform neurofibroma. Acta neuropathologica communications, 14(1), . https://doi.org/10.1186/s40478-026-02315-w

Chicago Style (17th ed.) Citation

M, Yue, et al. "Decreased PP2A Expression and Activity Represent a Therapeutic Target for Plexiform Neurofibroma." Acta Neuropathologica Communications 14, no. 1 (2026). https://doi.org/10.1186/s40478-026-02315-w.

MLA (9th ed.) Citation

M, Yue, et al. "Decreased PP2A Expression and Activity Represent a Therapeutic Target for Plexiform Neurofibroma." Acta Neuropathologica Communications, vol. 14, no. 1, 2026, https://doi.org/10.1186/s40478-026-02315-w.